- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Dynavax Technologies (DVAX)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 160.55 mm | 160.55 mm | 160.55 mm | 160.55 mm | 160.55 mm | 160.55 mm |
| Cash burn (monthly) | (no burn) | (no burn) | (no burn) | 3.38 mm | (no burn) | (no burn) |
| Cash used (since last report) | n/a | n/a | n/a | 7.72 mm | n/a | n/a |
| Cash remaining | n/a | n/a | n/a | 152.84 mm | n/a | n/a |
| Runway (months of cash) | n/a | n/a | n/a | 45.2 | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 260 |
| Opened positions | 41 |
| Closed positions | 34 |
| Increased positions | 96 |
| Reduced positions | 80 |
| 13F shares | Current |
|---|---|
| Total value | 1.65 tn |
| Total shares | 135.81 mm |
| Total puts | 351.30 k |
| Total calls | 470.90 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 21.23 mm | $271.14 bn |
| Deep Track Capital | 17.79 mm | $227.20 bn |
| Vanguard | 9.16 mm | $116.95 bn |
| STT State Street | 7.79 mm | $99.54 bn |
| Kynam Capital Management | 6.56 mm | $83.78 bn |
| Chicago Capital | 5.38 mm | $68.72 bn |
| Deerfield Management | 5.19 mm | $66.33 bn |
| Bain Capital Life Sciences Fund | 4.91 mm | $76.74 mm |
| Dimensional Fund Advisors | 4.07 mm | $51.95 bn |
| MS Morgan Stanley | 3.49 mm | $44.58 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 Aug 25 | Myers Scott Dunseth | Common Stock | Buy | Acquire P | No | No | 10.82 | 3,800 | 41.12 k | 35,004 |
| 22 Aug 25 | Deep Track Biotechnology Master Fund | Common Stock, par value $0.001 per share | Sell | Dispose S | No | No | 10.59 | 970,143 | 10.27 mm | 15,726,349 |
| 21 Aug 25 | Deep Track Biotechnology Master Fund | Common Stock, par value $0.001 per share | Sell | Dispose S | No | No | 11.03 | 1,094,994 | 12.08 mm | 16,696,492 |
| 11 Jun 25 | Cano Francis | Common Stock | Grant | Acquire A | No | No | 0 | 5,758 | 0.00 | 42,663 |
| 11 Jun 25 | Cano Francis | Stock Option Commont Stock | Grant | Acquire A | No | No | 10.18 | 28,500 | 290.13 k | 28,500 |
| 11 Jun 25 | Brent MacGregor | Common Stock | Grant | Acquire A | No | No | 0 | 5,758 | 0.00 | 21,829 |
| 11 Jun 25 | Brent MacGregor | Stock Option Commont Stock | Grant | Acquire A | No | No | 10.18 | 28,500 | 290.13 k | 28,500 |
| 11 Jun 25 | Elaine D Sun | Common Stock | Grant | Acquire A | No | No | 0 | 5,758 | 0.00 | 29,865 |
| 11 Jun 25 | Elaine D Sun | Stock Option Commont Stock | Grant | Acquire A | No | No | 10.18 | 28,500 | 290.13 k | 28,500 |